Saturday, 6 April 2019
SESSION III
|
8.30am to 9.10am
|
WHO 2016 Update on Myelodysplastic Syndromes
|
Prof. Robert Paul Hasserjian
Department of Pathology-WRN 244, Massachusetts General Hospital, USA
|
|
9.10am to 9.40am
|
The Role of Genomics in MDS
|
Dr. Felipe Prosper Cardoso
Head of the Hematology and Cell Therapy Department, University of Navarra, Spain
|
|
9.40am to 10am
|
Panel Discussion
|
|
|
10am to 10.15am
|
Coffee Break and Poster Viewing
|
|
10.15am to 10.45am
|
Update in Treatments of MDS
|
Prof. Ghulam Mufti
King's College Hospital, Denmark Hill, London, UK
|
|
10.45am to
11.15am
|
MDS in Qatar (Our Experience)
|
Dr. Amna Gamil
(NCCCR-HMC, Qatar)
|
|
11.15am to 11.40am
|
MPN in Oman
|
Dr. Murthada Al-Khabori
(Department of Heamtology - Oman)
|
|
11.40am to 1pm
|
Prayer & Lunch
|
SESSION IV
|
1pm to 1.30pm
|
Case-Based Lecture on MDS
|
Dr. Felipe Prosper Cardoso
University of Navarra, Spain
|
|
1.30pm to 2pm
|
WHO Updates of MPN
|
Prof. Robert Paul Hasserjian
Department of Pathology-WRN 244, Massachusetts General Hospital, USA
|
|
2pm to 2.20pm
|
Discontinuation Frequency of TKI’s in CML, Risk Factors and
Predator of Outcome
|
Ms. Nancy Kassem
(NCCCR-HMC, Qatar)
|
|
2.20pm to 2.50pm
|
Telomere Maintenance and MDS: Cause or Consequence? Or Clinical Usefulness of Somatic Mutations in MDS/CMML?
|
Prof. Ghulam Mufti
King's College Hospital, Denmark Hill, London, UK
|
|
2.50pm to 3.15pm
|
Invasive Fungal Infection in Malignant Hematology in Qatar
|
Dr. Anil Yousef Ellahie
(NCCCR-HMC, Qatar)
|
|
3.15pm to 3.35pm
|
CMML in Qatar
|
Dr. Samah Kohla
(NCCCR-HMC, Doha)
|
|
3.35pm to 3.50pm
|
Biobank Activities in Qatar
|
Dr. Said Ismael
(QSTP, Doha, Qatar)
|
|
3.50pm to 4.05pm
|
Supportive Measures in Hematology Malignancy
|
Dr. Azza Adel Hassan
(NCCCR-HMC, Qatar)
|
|
4.05pm to 4.15pm
|
Panel Discussion
|
|
|
4.15pm to 4.25pm
|
Closing Remarks
|
Prof. Alexander Knuth
|
